ClinicalTrials.Veeva

Menu

Infiltration Analgesia After Caesarean Section

N

North Karelia Central Hospital

Status and phase

Completed
Phase 4

Conditions

Caesarean Section
Pain, Postoperative

Treatments

Drug: Ropivacaine 0,75%
Drug: NaCl 0,9%

Study type

Interventional

Funder types

Other

Identifiers

NCT01094106
NCCHAne001

Details and patient eligibility

About

Infiltration of a local anesthetic into the surgical wound is a simple method to strive to control postoperative pain after surgery. In the investigators institution, this method is used quite often. However, there is a controversy regarding the analgesic efficacy. Moreover, the cost of the single use elastomeric pump used with this procedure is clearly higher than the costs of other routinely used analgesic methods.

According to the investigators observations, infiltration of a local anesthetic into the surgical wound after caesarean section seems to reduce the need for rescue analgesics. However, the scientific evidence of the efficacy of this technique is weak. The investigators decided to conduct a prospective, controlled, randomised, double blind trial on this topic.

The hypothesis is that wound infiltration with local anesthetic will reduce postoperative pain and opioid consumption after caesarean section without major adverse effects.

Enrollment

70 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • volunteer
  • age over 18 years
  • spinal anesthesia
  • ASA 1-2
  • no allergy to used medications
  • no medications which have effect on pain perception

Exclusion criteria

  • patient's refusal to participate
  • marked systemic disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

70 participants in 2 patient groups, including a placebo group

Ropivacaine 0,75%
Active Comparator group
Description:
Postoperative wound infusion 15 mg /h / 48h
Treatment:
Drug: Ropivacaine 0,75%
NaCl 0,9%
Placebo Comparator group
Description:
Postoperative wound infusion with NaCl 0,9% 2 ml /h /48h
Treatment:
Drug: NaCl 0,9%

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems